cqdm’s quantum leap pharma-led funding program for drug discovery research helps smes or canadian universities achieve innovative translational biopharmaceutical research projects. projects selected as part of the quantum leap program focus on developing cutting-edge technologies with the potential to significantly advance the r&d activities of cqdm’s pharmaceutical members. quantum leap projects are executed in close collaboration and with the expert support and funds of pharmaceutical members.

the enabling technologies, innovative platforms and/or innovative therapies derived from the quantum leap pharma-led funding program for drug discovery research are selected for their potential to significantly improve, facilitate and/or accelerate the drug discovery process and the development of safer and more effective drugs. the technologies of interest can be at any stage of the drug development process and involve a wide range of therapeutic indications.

projects are associated with specific deliverables and must be ready for use by cqdm pharmaceutical members upon completion. for scientists, the funded research opens new collaboration opportunities with world-class stakeholders in the industry.

parkinson canada is pleased to offer its graduate student award program (the “program”) as a strategic initiative to encourage promising young scientists to enter the field of parkinson's research and to invest in research training that offers promise for future work in the area of parkinson’s disease.    through this initiative, parkinson canada thus invites 世界杯2022赛程表淘汰赛 hip applications (“applications”) from those currently enrolled in a phd program committed to conducting research relevant to the cure, cause, prevention, improved treatment and/or understanding of parkinson’s disease or related disorders.  overall, this initiative is consistent with, and reflects, parkinson canada’s commitment to support innovation and renewal in the national parkinson’s research field and to foster international leadership potential in this area.

parkinson canada is pleased to offer its basic research fellowship program (the “program”) as a strategic initiative to encourage promising young scientists to enter the field of parkinson's research and to invest in research training that offers promise for future work in the area of parkinson’s disease. through this initiative, parkinson canada invites fellowship applications (“applications”) from applicants committed to  conducting research relevant to the cure, cause, prevention, improved treatment and/or understanding of parkinson’s disease or related disorders. this initiative is consistent with, and reflects, parkinson canada’s commitment to support innovation and renewal in the national parkinson’s research field and to foster international leadership potential in this area. 

parkinson canada is pleased to offer its clinical research fellowship program (the “program”) as a strategic initiative to encourage promising young scientists to enter the field of parkinson's clinical research and to invest in research training that offers promise for future work in the area of parkinson’s disease. through this initiative, parkinson canada thus invites fellowship applications from applicants committed to conducting research relevant to the cure, cause, prevention, improved treatment and/or understanding of parkinson’s disease or related disorders. this initiative is consistent with, and reflects, parkinson canada’s commitment to support innovation and renewal in the national parkinson’s research field and to foster international leadership potential in this area.  funds awarded under the program are to be used to cover salary, benefits and expenses for clinical research fellowships in parkinson's-related areas.

parkinson canada is pleased to offer the clinical movement disorders fellowship (the “program”) as a strategic initiative to encourage promising young clinicians to enter clinical training in the subspecialty of movement disorders, which will include parkinson’s disease. the purpose of this post-residency training is to provide expertise in the diagnosis and management of parkinson’s disease and may include other movement disorders.  clinical training is the largest component of this hands-on program (at least 80%) but could include an element of research.  however, this application will be evaluated solely on the clinical component.  parkinson canada wishes to ensure that each canadian with parkinson’s receives appropriate medical expertise, drug treatment, continuous care, education, respect, dignity, help and hope.  this program is an important component of parkinson canada’s plan to achieve its goal of ensuring that these critical elements in the day-to-day management of parkinson’s disease are accessible and available

parkinson canada is pleased to offer the pilot project program (the “program”) as part of its strategic initiative to encourage investigators (researchers) with faculty or equivalent appointments, to enter and perform research in new, specifically targeted, high priority areas of parkinson’s research in canada. the program is available to individuals who propose to conduct this research in the biomedical, clinical, health services and systems and population areas of parkinson’s. it is our intent that successful applicants will utilize the funds awarded to acquire preliminary data leading to development of larger projects eligible for funding from a major granting agency.    through this initiative, parkinson canada invites grant applications (“applications”) from applicants committed to conducting novel, emerging, or innovative research in areas relevant to the cure, cause, prevention, improved treatment and/or understanding of parkinson’s disease or related disorders. 

these grants fund partner-led initiatives to advance a partner challenge. maximum request: $150,000 for one year, with possibility of one year renewal, 1:1 matching required.

these grants further advance/translate projects with proof of concept and protected ip. maximum request: $150,000 for one year, 1:1 matching required.